Clinical Trial Update: A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2 [Phase 3]

View source ↗

Summary

Phase 3 trial results for fezolinetant evaluating reduction of moderate to severe hot flashes in menopausal women; sponsor-reported results were posted in June …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Fezolinetant (fezolinetant)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Hot Flashes | Phase 3 | Status: COMPLETED | Results posted: 2022-06-15